- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07303413
A Rhythmic and Auditory Approach for Children With Autism Spectrum Disorders (ASD) (THETABOOST)
December 18, 2025 updated by: Institut Pasteur
Approche Rythmique et Auditive Chez Les Enfants Avec Troubles du Spectre de l'Autisme (TSA)
The aim of this study is to assess the effectiveness of a rhythmic auditory training program in improving language skills in children with Autism Spectrum Disorder (ASD) who have a language acquisition disorder.
The program focuses on training children to reproduce the syllable rhythms of speech, and the study will evaluate the children's language skills before and after participating in the program.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
24
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- aged between 3 and 6 at the time of inclusion
- Have received a formal medical diagnosis of ASD
- Have the consent of the parent(s)
- Declaration of a language delay by the parents
- Affiliated to social security or equivalent scheme
Exclusion Criteria:
- Conditions likely to interfere with the EEG and make its interpretation difficult, including severe epilepsy or cerebral malformations.
- Treatments likely to interfere with the EEG (sedatives, psychostimulants, anxiolytics, antidepressants).
- Known hearing impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: short baseline
First baseline of 4 weeks and a second baseline of 8 weeks
|
EEG recording while listening to natural sounds
Children will have 4 images in front of them and a sound recording will be played to tell them which image to choose.
They will have to click on the one that corresponds to what was said in the sound recording.
|
|
Experimental: medium baseline
First baseline of 6 weeks and a second baseline of 6 weeks
|
EEG recording while listening to natural sounds
Children will have 4 images in front of them and a sound recording will be played to tell them which image to choose.
They will have to click on the one that corresponds to what was said in the sound recording.
|
|
Experimental: long baseline
First baseline of 8 weeks and a second baseline of 4 weeks
|
EEG recording while listening to natural sounds
Children will have 4 images in front of them and a sound recording will be played to tell them which image to choose.
They will have to click on the one that corresponds to what was said in the sound recording.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The difference in the progression of language acquisition measured by the difference in the number of images recognised in image recognition tests.
Time Frame: 12 weeks
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Comparison of Neural tracking of speech via EEG measurements of brain oscillatory activity before and after a session of listening to rhythmic sound.
Time Frame: 12 weeks
|
12 weeks
|
|
Comparison of theta/gamma frequency bands via EEG measurements of cerebral oscillatory activity before and after rhythmic auditory training
Time Frame: 12 weeks
|
12 weeks
|
|
Comparison of Phase Locking Value via EEG measurements of cerebral oscillatory activity before and after rhythmic auditory training
Time Frame: 12 weeks
|
12 weeks
|
|
Comparison of theta/gamma Phase-amplitude Coupling in auditory cortical areas via EEG measurements of cerebral oscillatory activity before and after rhythmic auditory training
Time Frame: 12 weeks
|
12 weeks
|
|
correlation between Neural tracking via EEG measurements of brain oscillatory activity during training and the language progression index.
Time Frame: 12 weeks
|
12 weeks
|
|
correlation between Phase Locking Value via EEG measurements of brain oscillatory activity during training and the language progression index.
Time Frame: 12 weeks
|
12 weeks
|
|
correlation between theta/gamma phase-amplitude coupling via EEG measurements of brain oscillatory activity during training and the language progression index.
Time Frame: 12 weeks
|
12 weeks
|
|
correlation between theta/gamma power via EEG measurements of brain oscillatory activity during training and the language progression index.
Time Frame: 12 weeks
|
12 weeks
|
|
correlation between Neural tracking via EEG measurements of brain oscillatory activity during training and the language progression index
Time Frame: 24 weeks
|
24 weeks
|
|
correlation between theta/gamma power via EEG measurements of brain oscillatory activity during training and the language progression index.
Time Frame: 24 weeks
|
24 weeks
|
|
correlation between theta/gamma phase-amplitude coupling via EEG measurements of brain oscillatory activity during training and the language progression index.
Time Frame: 24 weeks
|
24 weeks
|
|
correlation between Phase Locking Value via EEG measurements of brain oscillatory activity during training and the language progression index.
Time Frame: 24 weeks
|
24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Study Registration Dates
First Submitted
June 11, 2025
First Submitted That Met QC Criteria
December 18, 2025
First Posted (Actual)
December 24, 2025
Study Record Updates
Last Update Posted (Actual)
December 24, 2025
Last Update Submitted That Met QC Criteria
December 18, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-091_THETABOOST
- 2025-A00707-42 (Other Identifier: ID-RCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.